NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 09:57AM ET
5.25
Dollar change
-0.03
Percentage change
-0.57
%
Index- P/E- EPS (ttm)-1.64 Insider Own30.99% Shs Outstand7.42M Perf Week-2.96%
Market Cap38.96M Forward P/E- EPS next Y-0.04 Insider Trans0.82% Shs Float5.12M Perf Month5.00%
Enterprise Value35.13M PEG- EPS next Q-0.33 Inst Own19.84% Short Float7.52% Perf Quarter-21.52%
Income-12.23M P/S1.47 EPS this Y22.33% Inst Trans23.22% Short Ratio3.24 Perf Half Y-68.68%
Sales26.46M P/B8.92 EPS next Y97.03% ROA-81.75% Short Interest0.39M Perf YTD-67.61%
Book/sh0.59 P/C4.86 EPS next 5Y- ROE-276.15% 52W High19.49 -73.06% Perf Year-18.48%
Cash/sh1.08 P/FCF- EPS past 3/5Y28.60% 41.43% ROIC-149.48% 52W Low4.47 17.58% Perf 3Y-34.99%
Dividend Est.- EV/EBITDA- Sales past 3/5Y66.55% 60.15% Gross Margin85.22% Volatility7.84% 7.21% Perf 5Y-57.89%
Dividend TTM- EV/Sales1.33 EPS Y/Y TTM42.59% Oper. Margin-45.87% ATR (14)0.41 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.30 Sales Y/Y TTM41.54% Profit Margin-46.24% RSI (14)46.66 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.52 EPS Q/Q12.21% SMA20-1.75% Beta0.80 Target Price21.10
Payout- Debt/Eq0.96 Sales Q/Q23.44% SMA50-7.30% Rel Volume0.54 Prev Close5.28
Employees73 LT Debt/Eq0.87 EarningsMay 07 AMC SMA200-48.53% Avg Volume118.89K Price5.25
IPOJun 22, 2018 Option/ShortNo / Yes EPS/Sales Surpr.2.59% -1.86% Trades Volume7,476 Change-0.57%
Date Action Analyst Rating Change Price Target Change
Aug-14-20Upgrade BTIG Research Neutral → Buy $3.50
Nov-14-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-26-19Resumed Cantor Fitzgerald Neutral $9
May-30-19Downgrade Cantor Fitzgerald Overweight → Neutral
May-15-19Downgrade BTIG Research Buy → Neutral
May-09-19Initiated Noble Capital Markets Outperform
Sep-21-18Initiated Cantor Fitzgerald Overweight
May-09-25 11:00AM
May-07-25 11:18PM
11:16PM
06:15PM
04:05PM
01:36PM Loading…
01:36PM
May-05-25 04:48AM
May-02-25 08:00AM
May-01-25 08:00AM
Apr-30-25 08:00AM
Apr-17-25 08:00AM
Apr-16-25 08:00AM
Apr-03-25 08:00AM
Apr-01-25 08:00AM
Mar-31-25 08:00AM
03:11AM Loading…
Mar-13-25 03:11AM
Mar-12-25 05:15PM
04:05PM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-27-25 08:00AM
Feb-19-25 08:00AM
Feb-18-25 07:59AM
Feb-06-25 08:00AM
Feb-04-25 08:00AM
Jan-07-25 08:00AM
Jan-02-25 11:09AM
Dec-17-24 04:05PM
04:05PM
Nov-20-24 08:00AM
08:00AM Loading…
Nov-19-24 08:00AM
Nov-14-24 08:00AM
02:16AM
Nov-13-24 05:15PM
04:01PM
Nov-12-24 04:01PM
Nov-11-24 04:13AM
Nov-08-24 04:01PM
Oct-23-24 08:00AM
Oct-22-24 05:51PM
10:20AM
Oct-14-24 08:00AM
Oct-09-24 05:19PM
Sep-26-24 08:00AM
Sep-24-24 08:00AM
Sep-10-24 08:00AM
Sep-04-24 08:00AM
02:00AM
Aug-08-24 08:00AM
Aug-07-24 05:40PM
04:01PM
Aug-02-24 04:05PM
Aug-01-24 08:00AM
Jul-31-24 08:00AM
Jun-25-24 08:00AM
Jun-11-24 08:00AM
Jun-06-24 01:00PM
08:00AM
Jun-03-24 08:30AM
May-30-24 09:55AM
May-29-24 09:00AM
May-14-24 09:55AM
08:50AM
May-09-24 02:42PM
03:43AM
May-08-24 09:56PM
05:45PM
04:05PM
May-03-24 04:05PM
May-01-24 08:04AM
Apr-30-24 08:00AM
Apr-08-24 08:30AM
Apr-02-24 08:00AM
Mar-16-24 02:15PM
Mar-14-24 06:19AM
Mar-13-24 05:25PM
04:05PM
Mar-12-24 08:00AM
Mar-05-24 04:05PM
Feb-06-24 08:00AM
Jan-09-24 08:00AM
Dec-26-23 08:00AM
Dec-21-23 04:13PM
Dec-12-23 08:00AM
Nov-15-23 08:15AM
Nov-09-23 01:17PM
Nov-08-23 06:29PM
04:01PM
Nov-07-23 08:00AM
Oct-24-23 08:00AM
Oct-17-23 08:00AM
Oct-11-23 08:00AM
Oct-10-23 08:00AM
Oct-09-23 08:00AM
Oct-05-23 08:00AM
Sep-27-23 08:00AM
Sep-26-23 08:00AM
Sep-25-23 08:30AM
08:00AM
Sep-21-23 08:00AM
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GANDOLFO JOHN PDirectorMay 23 '25Buy5.011,8009,01869,087May 27 09:27 AM
Errico Thomas J.DirectorMay 12 '25Buy4.7710,00047,735266,401May 13 02:00 PM
Theofilos Charles SteveDirectorMar 25 '25Proposed Sale7.3965,000480,675Mar 25 10:26 AM
Goldberger Daniel SChief Executive OfficerMar 17 '25Buy8.591,0008,590290,565Mar 18 10:52 AM
Errico Thomas J.DirectorMar 17 '25Buy8.106,00048,585256,401Mar 17 08:00 PM
Errico Thomas J.DirectorAug 15 '24Buy6.125,00030,595233,818Aug 19 09:37 AM